Drug costs in context: assessing drug costs in cost-of-illness analyses

T Joseph Mattingly II, Shannon Weathers

Article Type

Commentary

Published

This article aims to provide contextual information for a general audience interested in conducting or evaluating cost-of-illness studies that may include drug costs and to describe key factors to consider when reviewing drug costs in the peer-reviewed literature.

Read more

Real-world use of inhaled nitric oxide therapy in patients with COVID-19 and mild-to-moderate acute respiratory distress syndrome

Steven H Abman, Nicholas R Fox, M Ibrahim Malik, Sneha S Kelkar, Shelby L Corman, Sanika Rege, Jenna Bhaloo, Rachel Shah, Ren-Jay Shei, Dana Saporito, Nisreen Shamseddine, Erik DeBoer, George J Wan, on behalf of the NOTICE Study Investigators

Article Type

Original Research

Published

This article aims to describe real-world inhaled nitric oxide use and outcomes in patients with COVID-19 with mild-to-moderate acute respiratory distress syndrome in the United States.

Read more

Real-world treatment patterns for repository corticotropin injection in patients with rheumatoid arthritis

Howard Busch, George J Wan, John Niewoehner, Parul Houston, Yujie Su, Cassie Clinton, Mary P Panaccio

Article Type

Original Research

Published

This study aims to describe real-world use and outcomes of patients with rheumatoid arthritis prescribed repository corticotropin injection in clinical practice through retrospective analysis of an electronic medical record database.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.